Clinical Trials Directory

Trials / Unknown

UnknownNCT02775513

Metabolism of Patients With Genetically Caused Cardiac Arrhythmia

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
University of Copenhagen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Loss-of-function mutations in voltage-gated potassium channels cause long QT syndrome (LQTS) due to a prolonged cardiac repolarisation phase. Hypoteses: patients with loss-of-function mutations also exhibit altered hormone release upon glucose ingestion.

Detailed description

Loss-of-function mutations in voltage-gated potassium channels cause long QT syndrome (LQTS) due to a prolonged cardiac repolarisation phase. Voltage-gated potassium (Kv-) channels are known for their relation to malignant cardiac arrhythmias, but also play a role in pancreatic alpha- and beta cell hormone secretion, and possibly in incretin hormone secretion. We hypothesised that patients with loss-of-function mutations also exhibit altered hormone release upon glucose ingestion.

Conditions

Timeline

Start date
2010-09-01
Primary completion
2016-05-01
First posted
2016-05-17
Last updated
2016-05-17

Source: ClinicalTrials.gov record NCT02775513. Inclusion in this directory is not an endorsement.